One Eye Is Good, but Two Are Better
Our work is only as good as our trials and our evidence. The evidence that we will use is from the cataract Patient Outcomes Research Team (PORT) study.[1] Mean preoperative vision was 20/83 and mean postoperative vision was 20/27, so we are looking at a utility change from 20/83 to 20/27. We use a 13-year model (obtained by taking the mean age from the study and adding up to life expectancy). We found after crunching those numbers that over that 13-year period, cataract surgery conferred a gain of 1.62 QALYs. This is hard to appreciate by itself, but if you convert that to the percentage gain in QOL, it comes out to 20.8%. That is the same as when we did a study headed up by Brandon Busbee[2] from our group. If you do both eyes (bilateral cataract surgery), you bump up the quality gain to 2.8, and the percentage improvement in QOL comes up to 36.2%.
What do these numbers mean? Is that a good number? They are great, but let me give you some comparisons. For the sake of comparison, when Zollinger-Ellison syndrome is treated with proton pump inhibitors, the QOL gain is 38%. Treating depression is about the same. Single-eye cataract surgery is about 20% (similar to treatment of glaucoma with timolol). For antihypertensive therapies, the QOL gain is 6%-9%, depending on which drug you use. Many people are on statins for hyperlipidemia. That improvement in QOL is 3%-5%. So you can see that for cataract surgery, that 20% for a single eye and 36% for the second eye is an amazing number. It's good to be able to quantify it. That is patient value.
Let's go to the third block -- economic analyses -- and look at the financial gain. This gets a little bit rough, a bit dry, so I will try hard to keep you interested. The direct medical cost for a unilateral cataract surgery in 2012 was $2653. We will call it $2600. You would probably be interested and not surprised to find out that it is 34% less than in 2000. These are the direct medical costs -- what we pay doctors, hospitals, and surgery centers. In 1985, this was 85% less, and out of that -- and this won't shock anybody -- the physician fee in 2012 is 90% less than it was in 1985. That is just an aside.
COMMENTARY
Improve Vision, Make Money
American Academy of Ophthalmology 2013
Melissa M. Brown, MD, MN, MBA
DisclosuresNovember 26, 2013
Editorial Collaboration
Medscape &
One Eye Is Good, but Two Are Better
Our work is only as good as our trials and our evidence. The evidence that we will use is from the cataract Patient Outcomes Research Team (PORT) study.[1] Mean preoperative vision was 20/83 and mean postoperative vision was 20/27, so we are looking at a utility change from 20/83 to 20/27. We use a 13-year model (obtained by taking the mean age from the study and adding up to life expectancy). We found after crunching those numbers that over that 13-year period, cataract surgery conferred a gain of 1.62 QALYs. This is hard to appreciate by itself, but if you convert that to the percentage gain in QOL, it comes out to 20.8%. That is the same as when we did a study headed up by Brandon Busbee[2] from our group. If you do both eyes (bilateral cataract surgery), you bump up the quality gain to 2.8, and the percentage improvement in QOL comes up to 36.2%.
What do these numbers mean? Is that a good number? They are great, but let me give you some comparisons. For the sake of comparison, when Zollinger-Ellison syndrome is treated with proton pump inhibitors, the QOL gain is 38%. Treating depression is about the same. Single-eye cataract surgery is about 20% (similar to treatment of glaucoma with timolol). For antihypertensive therapies, the QOL gain is 6%-9%, depending on which drug you use. Many people are on statins for hyperlipidemia. That improvement in QOL is 3%-5%. So you can see that for cataract surgery, that 20% for a single eye and 36% for the second eye is an amazing number. It's good to be able to quantify it. That is patient value.
Let's go to the third block -- economic analyses -- and look at the financial gain. This gets a little bit rough, a bit dry, so I will try hard to keep you interested. The direct medical cost for a unilateral cataract surgery in 2012 was $2653. We will call it $2600. You would probably be interested and not surprised to find out that it is 34% less than in 2000. These are the direct medical costs -- what we pay doctors, hospitals, and surgery centers. In 1985, this was 85% less, and out of that -- and this won't shock anybody -- the physician fee in 2012 is 90% less than it was in 1985. That is just an aside.
© 2013 WebMD, LLC
Cite this: Improve Vision, Make Money - Medscape - Nov 26, 2013.
Tables
References
Authors and Disclosures
Authors and Disclosures
Author
Melissa M. Brown, MD, MN, MBA
Professor of Ophthalmology, Thomas Jefferson University; Research Associate, Wills Eye Hospital, Philadelphia, Pennsylvania; CEO, Center for Value Based Medicine, Flourtown, Pennsylvania
Disclosure: Melissa M. Brown, MD, MN, MBA, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Center for Value-Based Medicine
Have a 5% or greater equity interest in: Center for Value-Based Medicine
Received income in an amount equal to or greater than $250 from: Center for Value-Based Medicine